PetMed Express, Inc.
PetMed Express, Inc. is classed by the SEC under Retail-Drug Stores and Proprietary Stores (industry code 5912), based in Delray Beach, FL. In its latest annual figures on file, for the fiscal year ended 2026-03-31, it reported revenue of $179 million and a loss of $57 million (its filed statements).
vs its business-model standard
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a retail business: prior from its industry code (SEC 5912, Retail-Drug Stores and Proprietary Stores); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 2.6 out of ten, 8 of 9 metrics filed and 1 estimated: past 2.0 out of ten, present 2.5 out of ten, future 3.4 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
- Surviving crises (past): 0.6 out of ten. 12 warning events since 2017; the latest 2025-12-29. 6th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Track record (past): 1.9 out of ten. -10.2% a year over 4 filed years; profitable in 1 of 4. 19th percentile among 16 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Shareholder treatment (past): 5.0 out of ten. CrossAssetData estimate 5.0/10, confidence 35 of 100 (one part). 50th percentile among 18 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
- Financial health (present): 3.9 out of ten. ROE -198%: lost 198¢ per shareholder dollar. Leverage 64%: owes 64¢ per asset dollar. 39th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Industry position (present): 1.5 out of ten. bottom 15% of 18 in its family; net margin -32%. 15th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Leadership (present): 1.0 out of ten. bottom 10% of 9 in its family for leadership; chief executive since 2026. 10th percentile among 9 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
- Room to expand (future): 4.4 out of ten. bottom 44% of 18 in its family for room to expand. 44th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Growth drivers (future): 4.8 out of ten. bottom 48% of 16 in its family for growth drivers. 48th percentile among 16 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Expectations vs reality (future): 0.9 out of ten. bottom 9% of 15 in its family for expectations against reality. 9th percentile among 15 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-06-02 for the period ended 2026-03-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-13 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-13 (on EDGAR). Newest filing: Form 4, 2026-09-29. Filings on record since 2000. Read from EDGAR 2026-10-12.
Who runs it
Willard, Jeffrey Allen (CEO and President); Campbell, Leslie C.g. (Interim CEO and President); Krulik, Douglas (CAO and Interim CFO); Elkeles, Tamar (director); Batushansky, Peter (director); Lacamp, James (director); Mennen, Justin L. (director); Fulgoni, Gian (director); Solivan, Leah (director). 9 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
This file: Overview · Past · Present · Future · Filings · every company on file
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.